Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
5.62M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
464K
-
Shares change
-
+403K
-
Total reported value, excl. options
-
$10.3M
-
Value change
-
+$9.2M
-
Number of buys
-
24
-
Number of sells
-
-2
-
Price
-
$21.70
Significant Holders of Nutex Health, Inc. - Common Stock, $0.001 par value (NUTX) as of Q3 2024
29 filings reported holding NUTX - Nutex Health, Inc. - Common Stock, $0.001 par value as of Q3 2024.
Nutex Health, Inc. - Common Stock, $0.001 par value (NUTX) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 464K shares
of 5.62M outstanding shares and own 8.26% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (92K shares), ESSEX INVESTMENT MANAGEMENT CO LLC (72.8K shares), MARSHALL WACE, LLP (69.6K shares), ONE PLUS ONE WEALTH MANAGEMENT, LLC (37.5K shares), BlackRock, Inc. (30.7K shares), GEODE CAPITAL MANAGEMENT, LLC (30.3K shares), TRUIST FINANCIAL CORP (29.1K shares), Legato Capital Management LLC (25K shares), THOMPSON DAVIS & CO., INC. (22.8K shares), and AVANTAX ADVISORY SERVICES, INC. (16K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.